You just read:

Intarcia Completes First Close of a Major Equity Financing; Poised for ITCA 650 NDA Filing for Type 2 Diabetes, Commercial Readiness and Pipeline Progression

News provided by

Intarcia Therapeutics, Inc.

15 Sep, 2016, 08:15 ET